(Q46713937)

24 December 2017

title

Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization (English)

1 reference

24 December 2017

author name string

Masahiro Yamada

1

1 reference

24 December 2017

Motoi Kushibiki

2

1 reference

24 December 2017

Tomohiro Osanai

3

1 reference

24 December 2017

Hirofumi Tomita

4

1 reference

24 December 2017

Ken Okumura

5

1 reference

24 December 2017

publication date

7 March 2008

1 reference

24 December 2017

published in

Cardiovascular Research

1 reference

24 December 2017

volume

79

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

169-178

1 reference

24 December 2017

Aldosterone induces a vascular inflammatory phenotype in the rat heart

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Nongenomic vascular action of aldosterone in the glomerular microcirculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Eplerenone blocks nongenomic effects of aldosterone on the Na+/H+ exchanger, intracellular Ca2+ levels, and vasoconstriction in mesenteric resistance vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Rapid nongenomic effects of aldosterone on human forearm vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Rapid cardiovascular action of aldosterone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Nongenomic effects of aldosterone in the human heart: interaction with angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

The angiotensin II AT2 receptor is an AT1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN064

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN064

1 reference

24 December 2017

1 reference

24 December 2017